These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38945198)
21. Sex differences in ochratoxin a toxicity in F344 rats after 7 and 21 days of daily oral administration. Pastor L; Vettorazzi A; Enciso JM; González-Peñas E; García-Jalón JA; Monreal JI; López de Cerain A Food Chem Toxicol; 2018 Jan; 111():363-373. PubMed ID: 29126803 [TBL] [Abstract][Full Text] [Related]
22. Epigenetic alterations of miR-155 and global DNA methylation as potential mediators of ochratoxin A cytotoxicity and carcinogenicity in human lung fibroblasts. Kharboush TG; Ahmed IA; Farag AA; Kharboush T; Sayed AEH; Abdel-Kareim AM; Al Mohaini M; Attia H; Eid RA; Zaki MSA; Al-Tabbakh AM Environ Sci Pollut Res Int; 2024 Jan; 31(4):5473-5483. PubMed ID: 38114706 [TBL] [Abstract][Full Text] [Related]
23. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Mantle P; Kulinskaya E; Nestler S Food Addit Contam; 2005; 22 Suppl 1():58-64. PubMed ID: 16332623 [TBL] [Abstract][Full Text] [Related]
24. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats. Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797 [TBL] [Abstract][Full Text] [Related]
25. The role of alpha2u-globulin in ochratoxin A induced renal toxicity and tumors in F344 rats. Rásonyi T; Schlatter J; Dietrich DR Toxicol Lett; 1999 Jan; 104(1-2):83-92. PubMed ID: 10048753 [TBL] [Abstract][Full Text] [Related]
26. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Castegnaro M; Mohr U; Pfohl-Leszkowicz A; Estève J; Steinmann J; Tillmann T; Michelon J; Bartsch H Int J Cancer; 1998 Jul; 77(1):70-5. PubMed ID: 9639396 [TBL] [Abstract][Full Text] [Related]
27. Biotransformation and nephrotoxicity of ochratoxin B in rats. Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343 [TBL] [Abstract][Full Text] [Related]
29. Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Horvath A; Upham BL; Ganev V; Trosko JE Toxicon; 2002 Mar; 40(3):273-82. PubMed ID: 11711124 [TBL] [Abstract][Full Text] [Related]
30. Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis. Stemmer K; Ellinger-Ziegelbauer H; Ahr HJ; Dietrich DR Cancer Res; 2007 May; 67(9):4052-68. PubMed ID: 17483316 [TBL] [Abstract][Full Text] [Related]
31. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Luhe A; Hildebrand H; Bach U; Dingermann T; Ahr HJ Toxicol Sci; 2003 Jun; 73(2):315-28. PubMed ID: 12700408 [TBL] [Abstract][Full Text] [Related]
32. Genomic analysis of Fisher F344 rat kidneys from a reproductive study following dietary ochratoxin A exposure. Carter LE; Bugiel S; Nunnikhoven A; Verster AJ; Bondy GS; Curran IHA Food Chem Toxicol; 2022 Sep; 167():113302. PubMed ID: 35843423 [TBL] [Abstract][Full Text] [Related]
33. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Cavin C; Delatour T; Marin-Kuan M; Holzhäuser D; Higgins L; Bezençon C; Guignard G; Junod S; Richoz-Payot J; Gremaud E; Hayes JD; Nestler S; Mantle P; Schilter B Toxicol Sci; 2007 Mar; 96(1):30-9. PubMed ID: 17110534 [TBL] [Abstract][Full Text] [Related]
34. Rat Tumour Histopathology Associated with Experimental Chronic Dietary Exposure to Ochratoxin A in Prediction of the Mycotoxin's Risk for Human Cancers. Herman D; Mantle P Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808971 [TBL] [Abstract][Full Text] [Related]
35. Oxidative damage and stress response from ochratoxin a exposure in rats. Gautier JC; Holzhaeuser D; Markovic J; Gremaud E; Schilter B; Turesky RJ Free Radic Biol Med; 2001 May; 30(10):1089-98. PubMed ID: 11369498 [TBL] [Abstract][Full Text] [Related]
36. Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes. Gautier J; Richoz J; Welti DH; Markovic J; Gremaud E; Guengerich FP; Turesky RJ Chem Res Toxicol; 2001 Jan; 14(1):34-45. PubMed ID: 11170506 [TBL] [Abstract][Full Text] [Related]
37. Effects of Chronic Ochratoxin A Exposure on p53 Heterozygous and p53 Homozygous Mice. Bondy GS; Caldwell DS; Aziz SA; Coady LC; Armstrong CL; Curran IH; Koffman RL; Kapal K; Lefebvre DE; Mehta R Toxicol Pathol; 2015 Jul; 43(5):715-29. PubMed ID: 25694087 [TBL] [Abstract][Full Text] [Related]
38. Renal lesions induced by ochratoxin A exposure in the F344 rat. Boorman GA; McDonald MR; Imoto S; Persing R Toxicol Pathol; 1992; 20(2):236-45. PubMed ID: 1475584 [TBL] [Abstract][Full Text] [Related]
39. Ochratoxin A induced premature senescence in human renal proximal tubular cells. Yang X; Liu S; Huang C; Wang H; Luo Y; Xu W; Huang K Toxicology; 2017 May; 382():75-83. PubMed ID: 28286205 [TBL] [Abstract][Full Text] [Related]
40. Strain-specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats. Son WC; Kamino K; Lee YS; Kang KS Int J Cancer; 2003 Jun; 105(3):305-11. PubMed ID: 12704662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]